ValuEngine Issues Buy Recommendation on GenMark Diagnostics

Emily Austin , Benzinga Staff Writer

July 27, 2011 6:18am Comments

ValuEngine issued a Buy recommendation on GenMark Diagnostics (NASDAQ: GNMK). On Tuesday, GNMK lost 2.85% of its value to finish the day at $5.11.

Posted-In: ValuEngine Initiation Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	$SOL, $BTC: Anthony Scaramucci May Not Have Seen Eye-To-Eye With Trump On Crypto,...
2	JPM, AMZN: When Jamie Dimon's Daughter Asked If They Have To '...
3	LMT, LHX: Trump's $151 Billion 'Golden Dome' Shi...
4	UBER, INTC: Consumer Tech News (July 21–July 25): Big...
5	IONQ, HIMS: Benzinga's 'Stock Whisp...
6	CHTR, UNH: Chipotle Mexican Grill,...
7	BRK, $BTC: Marjorie Taylor...

1	TSLA: Elon Musk Calls Orbital Refueling Starship's Next Challenge: 'I Sp...
2	BTC, $BTC: Bitcoin, Ethereum, Dogecoin Climb On Trump-EU Trade Pact — Analys...
3	Google Deepmind Chief Thinks There's Only A Half Chance Of AI...
4	TSLA, NVDA: Elon Musk Confirms Tesla As the Mystery Big-Tech That Sig...
5	Trump's New EU Trade Deal Labeled 'Bad News...
6	TSM, AAPL: Trump's $550 Billion Japan Trade Deal Could...
7	Trump's Fentanyl Tariffs In Beijing's...

Market Overview